Diabetes, growth hormone-insulin-like growth factor pathways and association to benign prostatic hyperplasia.
Differentiation., 82(4-5):261-71 (2011)
Smaller prostate gland size and older age predict Gleason score upgrading.
A close surgical margin after radical prostatectomy is an independent predictor of recurrence.
J. Urol., Jul;188(1):91-7 (2012)
Impact on the clinical outcome of prostate cancer by the 2005 international society of urological pathology modified Gleason grading system.
Am. J. Surg. Pathol., Jun;36(6):838-43 (2012)
Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer.
J. Clin. Oncol., Sep;30(25):3071-6 (2012)
pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2.
Mol. Cell., Oct;28(1):15-27 (2007)
Low-dose 12-O-tetradecanoylphorbol-13-acetate enhances tumor necrosis factor related apoptosis-inducing ligand induced apoptosis in prostate cancer cells.
Clin. Cancer Res., Dec;13(23):7181-90 (2007)
The hybrid of basic science and clinical training for the urologic oncologist: Necessity or waste?
Urol. Oncol., 27(2):205-7 (2009)
Men with organ-confined prostate cancer and positive surgical margins develop biochemical failure at a similar rate to men with extracapsular extension.
Urology., Jul;78(1):121-5 (2011)
Calculated volume of prostate cancer identifies patients with clinical stage T1C disease at high risk of biochemical recurrence after radical prostatectomy: a preliminary study.
Urology., Aug;56(2):273-7 (2000)
Self-retraction clamp for dissection of the posterior prostatic fossa during radical retropubic prostatectomy.
ScientificWorldJournal., Jun;4 Suppl 1:260-2 (2004)
MG-132 sensitizes TRAIL-resistant prostate cancer cells by activating c-Fos/c-Jun heterodimers and repressing c-FLIP(L).
Cancer Res., Mar;67(5):2247-55 (2007)
Hypoxia-inducible factor linked to differential kidney cancer risk seen with type 2A and type 2B VHL mutations.
Mol. Cell. Biol., Aug;27(15):5381-92 (2007)
Stromally expressed c-Jun regulates proliferation of prostate epithelial cells.
Am. J. Pathol., Oct;171(4):1189-98 (2007)
c-Fos as a proapoptotic agent in TRAIL-induced apoptosis in prostate cancer cells.
Cancer Res., Oct;67(19):9425-34 (2007)
Leydig cell hyperplasia mimicking testicular neoplasm.
Urology., Oct;48(4):647-9 (1996)
F-box protein 10, an NF-ÎºB-dependent anti-apoptotic protein, regulates TRAIL-induced apoptosis through modulating c-Fos/c-FLIP pathway.
Cell Death Differ., Jul;18(7):1184-95 (2011)
MR imaging of renal masses: correlation with findings at surgery and pathologic analysis.
Radiographics., 28(4):985-1003 (2008)
Repression of NF-kappaB and activation of AP-1 enhance apoptosis in prostate cancer cells.
Int. J. Cancer., Apr;124(8):1980-9 (2009)
Reduced levels of 5-Î± reductase 2 in adult prostate tissue and implications for BPH therapy.
Prostate., Sep;71(12):1317-24 (2011)